Survey among healthcare professionals (neurologists treating patients with MS along with MS specialist nurses) and patients in selected European countries plus Canada to evaluate the knowledge required for the safe use of Mayzent (siponimod)

22/12/2021
18/12/2025
EU PAS number:
EUPAS44782
Study
Finalised

ENCePP Code of conduct

No
Data sources

Data sources (types)

Other
Patient surveys

Data sources (types), other

For Healthcare professionals: eligibility materials administered through recruitment screener document, self-administered online survey questionnaire;
For Patients: eligibility materials administered through recruitment screener document, self-administered online survey questionnaire
Use of a Common Data Model (CDM)

CDM mapping

No
Data quality specifications

Check conformance

Unknown

Check completeness

Unknown

Check stability

Unknown

Check logical consistency

Unknown
Data characterisation

Data characterisation conducted

No